News Conference News ACC 2021 Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF Michael O'Riordan May 25, 2021
News Conference News SCAI 2021 ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later Michael O'Riordan May 06, 2021
News Daily News Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval Michael O'Riordan March 03, 2021
News Daily News Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic Michael O'Riordan January 12, 2021
News Daily News ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show Michael O'Riordan December 21, 2020
News Daily News AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More Shelley Wood December 17, 2020
News Conference News AHA 2020 INVESTED: No Added CV Benefit From High-Dose Flu Vaccine Todd Neale November 17, 2020
News Conference News AHA 2020 Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON Michael O'Riordan November 15, 2020
News Daily News Free CAC Scans for ASCVD Risk Capture More Women, Minorities, and Low-Income Adults Michael O'Riordan September 02, 2020
News Daily News Could Statins Curb Fatal or Severe COVID-19? Some Clues Michael O'Riordan August 14, 2020
News Daily News Less MI, CV Death With Noninvasive Testing for Chest Pain: Observational Data Michael O'Riordan July 14, 2020
News Daily News Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE Michael O'Riordan July 08, 2020
News Daily News Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19 Michael O'Riordan June 08, 2020
News Conference News ACC 2020 ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up Shelley Wood March 30, 2020
News Daily News Missed Opportunities: Many HF Patients Not Tested for CAD L.A. McKeown March 20, 2020
News Daily News Type 2 MI Linked to More CV Deaths, Even in Younger Patients Shelley Wood March 04, 2020
News Daily News Free Pass? Lifestyle Slips for Patients Starting Certain Preventive Meds Michael O'Riordan February 06, 2020
News Features ‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry Michael O'Riordan January 10, 2020
News Conference News AHA 2019 More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA Michael O'Riordan November 14, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2019 Shelley Wood October 01, 2019